Medtronic is upping the ante in patent dispute with competitor Axonics Inc. that has already lasted more than four years. The dispute centers on Medtronic's InterStim device, an implanted ...
Bladder control problems affect an estimated 43 million – or one in six – U.S. adults. Of those, nearly 16 million people have urge urinary incontinence, a common symptom of overactive bladder (OAB) ...
Add Yahoo as a preferred source to see more of our stories on Google. The partnership aims to broaden the range of support services available to individuals experiencing bladder control issues. Credit ...
Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...
The Implantable Tibial Neuromodulation (ITNM) device will expand treatment options for the 16 million people living with urinary urges and involuntary leaks Bladder control problems affect an ...
Medtronic, the medical device manufacturer, and Medtronic Logistics sued Axonics on Feb. 28 in Delaware District Court over patent infringement claims. The lawsuit, asserting two patents related to ...
Health Care To treat a common bladder condition, Medtronic implant goes under the skin near the ankle The Minnesota medtech company’s Altaviva implant just secured FDA approval. It treats urinary urge ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results